Skip to main content
logo
Ondine Biomedical Inc. (AIM:OBI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
13.75
0.00 (0.00%)
Aug 14, 2026, 2:47 PM GMT

Ondine Biomedical Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7139362040108
Market Cap Growth
10.91%9.33%79.20%-50.26%-63.06%-
Enterprise Value
6636351827109
Last Close Price
0.140.090.090.090.200.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
49.8227.1131.2627.74101.9672.03
PB Ratio
37.8320.589.3116.015.596.24
P/TBV Ratio
37.8320.589.3116.015.596.24

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
45.9925.2430.8224.9069.7472.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.120.120.020.260.120.02
Net Debt / Equity Ratio
-2.91-2.91-1.40-1.17-1.01-1.00
Net Debt / EBITDA Ratio
0.340.340.500.170.631.72
Net Debt / FCF Ratio
0.420.420.620.180.712.35
Asset Turnover
0.200.200.220.110.030.14
Inventory Turnover
0.670.670.620.420.301.80
Quick Ratio
1.021.021.730.953.417.81
Current Ratio
1.231.232.051.363.878.54
Return on Equity (ROE)
-569.72%-569.72%-426.20%-209.95%-93.81%-
Return on Assets (ROA)
-137.70%-137.70%-130.98%-82.98%-46.25%-59.55%
Return on Capital Employed (ROCE)
-835.70%-835.70%-282.70%-659.80%-148.20%-58.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.39%-41.15%-29.82%-43.18%-29.78%-27.07%
FCF Yield
-18.18%-33.41%-24.20%-41.44%-25.60%-6.82%
Buyback Yield / Dilution
-69.37%-69.37%-39.31%-1.30%-144.34%-12.69%